Treatment with angiotensin converting enzyme inhibitors, angiotensin-II-antagonists and beta-blockers in an unselected group of patients with chronic heart failure

被引：0
|
作者：
Ragnar Watz
Ann-Britt Ekstrand
Victoria Engelbrektson
Björn Beermann
机构：
[1] Kristinehamn’s Hospital,Department of Medicine
[2] Medical Products Agency,undefined
来源：
European Journal of Clinical Pharmacology | 2005年 / 61卷
关键词：
Heart Failure; Chronic Heart Failure; Heart Failure Patient; Carvedilol; Angiotensin Converting Enzyme Inhibitor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：209 / 214
页数：5
相关论文
共 50 条
  • [41] Effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with chronic kidney disease
    Kolesnyk, I.
    Struijk, D. G.
    Dekker, F. W.
    Krediet, R. T.
    NETHERLANDS JOURNAL OF MEDICINE, 2010, 68 (01): : 15 - 23
  • [42] Angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists
    Kyrmizakis, DE
    Papadakis, CE
    Liolios, AD
    Karatzanis, AD
    Malandrakis, S
    Skoulakis, CE
    Bizakis, JG
    Velegrakis, GA
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2004, 130 (12) : 1416 - 1419
  • [43] Comparison between angiotensin converting enzyme inhibitors and angiotensin II antagonists
    Asmar, R
    Madonna, O
    Brisac, AM
    Benetos, A
    Laurent, S
    THERAPIE, 1998, 53 (03): : 253 - 270
  • [44] Angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in the treatment of heart failure caused by left ventricular systolic dysfunction
    Sander, GE
    McKinnie, JJ
    Greenberg, SS
    Giles, TD
    PROGRESS IN CARDIOVASCULAR DISEASES, 1999, 41 (04) : 265 - 300
  • [45] The evidence for β blockers in heart failure -: Equals or surpasses that for angiotensin converting enzyme inhibitors
    Cleland, JGF
    McGowan, J
    Clark, A
    Freemantle, N
    BRITISH MEDICAL JOURNAL, 1999, 318 (7187): : 824 - 825
  • [46] Safety and Prognostic Impact of Early Treatment with Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Patients with Acute Heart Failure
    Kenji Yoshioka
    Yuya Matsue
    Tetsuo Yamaguchi
    Takeshi Kitai
    Nobuyuki Kagiyama
    Takahiro Okumura
    Keisuke Kida
    Shogo Oishi
    Eiichi Akiyama
    Satoshi Suzuki
    Masayoshi Yamamoto
    Shunsuke Kuroda
    Akihiko Matsumura
    Kenzo Hirao
    American Journal of Cardiovascular Drugs, 2019, 19 : 597 - 605
  • [47] Safety and Prognostic Impact of Early Treatment with Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Patients with Acute Heart Failure
    Yoshioka, Kenji
    Matsue, Yuya
    Yamaguchi, Tetsuo
    Kitai, Takeshi
    Kagiyama, Nobuyuki
    Okumura, Takahiro
    Kida, Keisuke
    Oishi, Shogo
    Akiyama, Eiichi
    Suzuki, Satoshi
    Yamamoto, Masayoshi
    Kuroda, Shunsuke
    Matsumura, Akihiko
    Hirao, Kenzo
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2019, 19 (06) : 597 - 605
  • [48] Balance between angiotensin converting enzyme and angiotensin converting enzyme 2 in patients with chronic heart failure
    Wang, Jiang
    Li, Nan
    Gao, Feng
    Song, Rong
    Zhu, Shanjun
    Geng, Zhaohua
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2015, 16 (03) : 553 - 558
  • [49] USE OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS, ANGIOTENSIN RECEPTOR BLOCKERS AND RISK OF DEMENTIA IN HEART FAILURE
    Chitnis, A. S.
    Johnson, M. L.
    Aparasu, R. R.
    Chen, H.
    Kunik, M. E.
    Schulz, P. E.
    VALUE IN HEALTH, 2013, 16 (03) : A11 - A11
  • [50] Sex differences in the effectiveness of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in patients with congestive heart failure - Reply
    Hudson, Marie
    Rahme, Elham
    Behlouli, Hassan
    Sheppard, Richard
    Pilote, Louise
    EUROPEAN JOURNAL OF HEART FAILURE, 2007, 9 (09) : 964 - 964
12345